FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Harold Windschitl

Research Profile

Chemicals & Drugs

Procedures

Disorders

Activities & Behaviors

Drug Evaluation

Concepts & Ideas

Co-author Network

Publications

TOP 3
Nadia N Laack; Roscoe F Morton; Judith Rich O'Fallon; Brian Patrick O'Neill; Eduardo R Pajon; Bernd W Scheithauer; Harold E Windschitl; Karla V Ballman; Paul D Brown; Xiomara W Carrero; Joseph P Colgan; Tom R Fitch; Mark R Gilbert; Thomas M Habermann; Roland B Hawkins; Paul J Kurtin
CHOD/BVAM chemotherapy and whole-brain radiotherapy for newly diagnosed primary central nervous system lymphoma.
Rafaela L Rego; Nathan R Foster; Thomas C Smyrk; M Le; Michael J O'Connell; Daniel J Sargent; Harold E Windschitl; Frank A Sinicrope
Prognostic effect of activated EGFR expression in human colon carcinomas: comparison with EGFR status.
Grace K Dy; Timothy J Hobday; Garth Nelson; Harold E Windschitl; Michael J O'Connell; Steven R Alberts; Richard M Goldberg; Daniel A Nikcevich; Daniel J Sargent
Long-term survivors of metastatic colorectal cancer treated with systemic chemotherapy alone: a North Central Cancer Treatment Group review of 3811 patients, N0144.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Harold Windschitl (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Nadia N Laack; Roscoe F Morton; Judith Rich O'Fallon; Brian Patrick O'Neill; Eduardo R Pajon; Bernd W Scheithauer; Harold E Windschitl; Karla V Ballman; Paul D Brown; Xiomara W Carrero; Joseph P Colgan; Tom R Fitch; Mark R Gilbert; Thomas M Habermann; Roland B Hawkins; Paul J Kurtin
CHOD/BVAM chemotherapy and whole-brain radiotherapy for newly diagnosed primary central nervous system lymphoma.
International journal of radiation oncology, biology, physics 2011;81(2):476-82.
2010: Rafaela L Rego; Nathan R Foster; Thomas C Smyrk; M Le; Michael J O'Connell; Daniel J Sargent; Harold E Windschitl; Frank A Sinicrope
Prognostic effect of activated EGFR expression in human colon carcinomas: comparison with EGFR status.
British journal of cancer 2010;102(1):165-72.
2009: Grace K Dy; Timothy J Hobday; Garth Nelson; Harold E Windschitl; Michael J O'Connell; Steven R Alberts; Richard M Goldberg; Daniel A Nikcevich; Daniel J Sargent
Long-term survivors of metastatic colorectal cancer treated with systemic chemotherapy alone: a North Central Cancer Treatment Group review of 3811 patients, N0144.
Clinical colorectal cancer 2009;8(2):88-93.
2008: Frank A Sinicrope; Rafaela L Rego; Kenji Okumura; Nathan R Foster; Michael J O'Connell; Daniel J Sargent; Harold E Windschitl
Prognostic impact of bim, puma, and noxa expression in human colon carcinomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(18):5810-8.
2008: Frank A Sinicrope; Rafaela L Rego; Nathan R Foster; Stephen N Thibodeau; Steven R Alberts; Harold E Windschitl; Daniel J Sargent
Proapoptotic Bad and Bid protein expression predict survival in stages II and III colon cancers.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(13):4128-33.
2008: Amy J French; Daniel J Sargent; Lawrence J Burgart; Nathan R Foster; Brian F Kabat; Richard M Goldberg; Lois E Shepherd; Harold E Windschitl; Stephen N Thibodeau
Prognostic significance of defective mismatch repair and BRAF V600E in patients with colon cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(11):3408-15.
2008: Elizabeth A Johnson; Randolph S Marks; Sumithra J Mandrekar; Shauna Hillman; Mark D Hauge; Mitchel D Bauman; Edward J Wos; Dennis F Moore; John W Kugler; Harold E Windschitl; David Graham; Albert M Bernath; Tom R Fitch; Gamini S Soori; James R Jett; Alex A. Adjei; Edith A Perez
Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51).
Lung cancer (Amsterdam, Netherlands) 2008;60(2):200-7.
2007: Charles L Loprinzi; Debra L. Barton; Aminah Jatoi; Jeff Sloan; Jim Martenson; David Steensma; Ravi Rao; Paul J Novotny; Amit Sood; Axel Grothey; Lori Minasian; Harold E Windschitl
Symptom control trials: a 20-year experience.
The journal of supportive oncology 2007;5(3):119-25, 128.
2006: Frank A Sinicrope; Rafaela L Rego; Nathan Foster; Daniel J Sargent; Harold E Windschitl; Lawrence J Burgart; Thomas E Witzig; Stephen N Thibodeau
Microsatellite instability accounts for tumor site-related differences in clinicopathologic variables and prognosis in human colon cancers.
The American journal of gastroenterology 2006;101(12):2818-25.
2006: Michael J O'Connell; Daniel J Sargent; Harold E Windschitl; Lois Shepherd; Michelle R Mahoney; James E Krook; Sandra Rayson; Roscoe F Morton; Kendrith M Rowland; John W Kugler
Randomized clinical trial of high-dose levamisole combined with 5-fluorouracil and leucovorin as surgical adjuvant therapy for high-risk colon cancer.
Clinical colorectal cancer 2006;6(2):133-9.
2005: Cynthia X Ma; Suresh Nair; Sachdev Thomas; Sumithra J Mandrekar; Daniel A Nikcevich; Kendrith M Rowland; Tom R Fitch; Harold E Windschitl; Shauna Hillman; Steven E Schild; James R Jett; Coleman K Obasaju; Alex A. Adjei
Randomized phase II trial of three schedules of pemetrexed and gemcitabine as front-line therapy for advanced non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(25):5929-37.
2005: Steven R Alberts; Hani Al-Khatib; Michelle R Mahoney; Lawrence J Burgart; Peter J Cera; Patrick J Flynn; Tom R Finch; Ralph Levitt; Harold E Windschitl; James A Knost; Loren K Tschetter
Gemcitabine, 5-fluorouracil, and leucovorin in advanced biliary tract and gallbladder carcinoma: a North Central Cancer Treatment Group phase II trial.
Cancer 2005;103(1):111-8.
2004: Megan M Garrity; Lawrence J Burgart; Michelle R Mahoney; Harold E Windschitl; Muhammad Salim; Martin Wiesenfeld; James E Krook; John C Michalak; Richard M Goldberg; Michael J O'Connell; Alfred F Furth; Daniel J Sargent; Linda M Murphy; Eunice Hill; Darren L Riehle; Cecelia H Meyers; Thomas E Witzig
Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(9):1572-82.
2002: Aminah Jatoi; Harold E Windschitl; Charles L Loprinzi; Jeff A Sloan; Shaker R Dakhil; James A Mailliard; Sarode Pundaleeka; Carl G Kardinal; Tom R Fitch; James E Krook; Paul J Novotny; Brad Christensen
Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(2):567-73.
2002: Aminah Jatoi; Jun-ichi Yamashita; Jeff A Sloan; Paul J Novotny; Harold E Windschitl; Charles L Loprinzi
Does megestrol acetate down-regulate interleukin-6 in patients with cancer-associated anorexia and weight loss? A North Central Cancer Treatment Group investigation.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2002;10(1):71-5.
2001: Gerardo Colon-Otero; R D Niedringhaus; S H Hillman; Susan Geyer; J Sloan; James E Krook; Harold E Windschitl; Randolph S Marks; Martin Wiesenfeld; Loren K Tschetter; J J Jett
A phase II trial of edatrexate, vinblastine, adriamycin, cisplastin, and filgrastim (EVAC/G-CSF) in patients with non-small-cell carcinoma of the lungs: a North Central Cancer Treatment Group Trial.
American journal of clinical oncology 2001;24(6):551-5.
2001: Jeff A Sloan; Charles L Loprinzi; Paul J Novotny; Debra L. Barton; Beth I Lavasseur; Harold E Windschitl
Methodologic lessons learned from hot flash studies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(23):4280-90.
2001: Aminah Jatoi; Charles L Loprinzi; Jeff A Sloan; George G Klee; Harold E Windschitl
Neuropeptide Y, leptin, and cholecystokinin 8 in patients with advanced cancer and anorexia: a North Central Cancer Treatment Group exploratory investigation.
Cancer 2001;92(3):629-33.
2000: Patrick A Burch; C Ghosh; Georgene Schroeder; Cristine Allmer; C L Woodhouse; Richard M Goldberg; Ferdinand K Addo; Albert M Bernath; Loren K Tschetter; Harold E Windschitl; Charles D Cobau
Phase II evaluation of continuous-infusion 5-fluorouracil, leucovorin, mitomycin-C, and oral dipyridamole in advanced measurable pancreatic cancer: a North Central Cancer Treatment Group Trial.
American journal of clinical oncology 2000;23(5):534-7.
1999: RJ Kirschling; JP Grill; Randolph S Marks; John W Kugler; JB Gerstner; Steven A Kuross; John C Michalak; Harold E Windschitl; K D Krewer; James R Jett
Paclitaxel and G-CSF in previously untreated patients with extensive stage small-cell lung cancer: a phase II study of the North Central Cancer Treatment Group.
American journal of clinical oncology 1999;22(5):517-22.
1999: Charles L Loprinzi; John W Kugler; Jeff A Sloan; Thom W Rooke; Susan K Quella; Paul J Novotny; R B Mowat; John C Michalak; Philip J Stella; Ralph Levitt; Loren K Tschetter; Harold E Windschitl
Lack of effect of coumarin in women with lymphedema after treatment for breast cancer.
The New England journal of medicine 1999;340(5):346-50.
1997: Henry C Pitot; Donald B Wender; Michael J O'Connell; Georgene Schroeder; Richard M Goldberg; Joseph Rubin; James A Mailliard; James A Knost; C Ghosh; RJ Kirschling; Ralph Levitt; Harold E Windschitl
Phase II trial of irinotecan in patients with metastatic colorectal carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(8):2910-9.
1997: Charles L Loprinzi; Samir Abu-Ghazaleh; Jeff A Sloan; C vanHaelst-Pisani; A M Hammer; Kendrith M Rowland; M Law; Harold E Windschitl; J S Kaur; Neil Ellison
Phase III randomized double-blind study to evaluate the efficacy of a polycarbophil-based vaginal moisturizer in women with breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(3):969-73.
1997: James N Ingle; D I Twito; Vera J Suman; James E Krook; J A Maillard; Harold E Windschitl; RF Marschke
Evaluation of intravenous 6-thioguanine as first-line chemotherapy in women with metastatic breast cancer.
American journal of clinical oncology 1997;20(1):69-72.
1995: Thomas E Witzig; Louis Letendre; JB Gerstner; Georgene Schroeder; James A Mailliard; G Colon-Otero; RF Marschke; Harold E Windschitl
Evaluation of a somatostatin analog in the treatment of lymphoproliferative disorders: results of a phase II North Central Cancer Treatment Group trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(8):2012-5.
1995: J H Donohue; S Williams; S Cha; Harold E Windschitl; Thomas E Witzig; H Nelson; R J Fitzgibbons; H S Wieand; CG Moertel
Perioperative blood transfusions do not affect disease recurrence of patients undergoing curative resection of colorectal carcinoma: a Mayo/North Central Cancer Treatment Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(7):1671-8.
1992: J A Laurie; Richard G Hahn; Terry M Therneau; S R Patel; James A Mailliard; Harold E Windschitl; D I Twito; Roscoe F Morton; James E Krook
Chemotherapy for hormonally refractory advanced prostate carcinoma. A comparison of combined versus sequential treatment with mitomycin C, doxorubicin, and 5-fluorouracil.
Cancer 1992;69(6):1440-4.
1991: James N Ingle; James A Mailliard; Daniel J Schaid; James E Krook; Dean H Gesme; Harold E Windschitl; D M Pfeifle; P S Etzell; J G Gerstner; H J Long
A double-blind trial of tamoxifen plus prednisolone versus tamoxifen plus placebo in postmenopausal women with metastatic breast cancer. A collaborative trial of the North Central Cancer Treatment Group and Mayo Clinic.
Cancer 1991;68(1):34-9.
1991: James N Ingle; D I Twito; Daniel J Schaid; S A Cullinan; James E Krook; James A Mailliard; Loren K Tschetter; H J Long; J G Gerstner; Harold E Windschitl
Combination hormonal therapy with tamoxifen plus fluoxymesterone versus tamoxifen alone in postmenopausal women with metastatic breast cancer. An updated analysis.
Cancer 1991;67(4):886-91.
1990: Harold E Windschitl; Michael J O'Connell; H S Wieand; James E Krook; Joseph Rubin; CG Moertel; John W Kugler; D M Pfeifle; Richard M Goldberg; J A Laurie
A clinical trial of biochemical modulation of 5-fluorouracil with N-phosphonoacetyl-L-aspartate and thymidine in advanced gastric and anaplastic colorectal cancer.
Cancer 1990;66(5):853-6.
1990: S R Patel; L K Kvols; Richard G Hahn; Harold E Windschitl; Ralph Levitt; Terry M Therneau
A phase II randomized trial of megestrol acetate or dexamethasone in the treatment of hormonally refractory advanced carcinoma of the prostate.
Cancer 1990;66(4):655-8.
1990: R W Beart; C G Moertel; H S Wieand; J E Leigh; Harold E Windschitl; Jon A. van Heerden; R J Fitzgibbons; B G Wolff
Adjuvant therapy for resectable colorectal carcinoma with fluorouracil administered by portal vein infusion. A study of the Mayo Clinic and the North Central Cancer Treatment Group.
Archives of surgery (Chicago, Ill. : 1960) 1990;125(7):897-901.
1989: RF Marschke; James N Ingle; Daniel J Schaid; James E Krook; James A Mailliard; S A Cullinan; D M Pfeifle; Henry Votava; Larry P Ebbert; Harold E Windschitl
Randomized clinical trial of CFP versus CMFP in women with metastatic breast cancer.
Cancer 1989;63(10):1931-7.
1988: James N Ingle; D I Twito; Daniel J Schaid; S A Cullinan; James E Krook; James A Mailliard; RF Marschke; H J Long; J G Gerstner; Harold E Windschitl
Randomized clinical trial of tamoxifen alone or combined with fluoxymesterone in postmenopausal women with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(5):825-31.
1986: James N Ingle; James E Krook; S J Green; T P Kubista; L K Everson; D L Ahmann; M N Chang; H F Bisel; Harold E Windschitl; D I Twito
Randomized trial of bilateral oophorectomy versus tamoxifen in premenopausal women with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1986;4(2):178-85.
1985: James E Krook; James R Jett; T R Fleming; Robert J Dalton; RF Marschke; S A Cullinan; Harold E Windschitl; L K Everson; F S Brunk; J A Laurie
A controlled evaluation of combined 5-fluorouracil, doxorubicin, and mitomycin C (FAM) for the treatment of advanced non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1985;3(6):842-8.
1985: S A Cullinan; CG Moertel; T R Fleming; J R Rubin; J E Krook; L K Everson; Harold E Windschitl; D I Twito; RF Marschke; J F Foley
A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin.
JAMA : the journal of the American Medical Association 1985;253(14):2061-7.
1985: James E Krook; James N Ingle; S J Green; W D Bowman; L K Everson; Harold E Windschitl; RF Marschke; J A Laurie; S A Cullinan; D M Pfeifle
Randomized clinical trial of cyclophosphamide, 5-FU, and prednisone with or without tamoxifen in postmenopausal women with advanced breast cancer.
Cancer treatment reports 1985;69(4):355-61.
1983: Harold E Windschitl; M Scott; A Schutt; G McCormack; L Everson; S Cullinan; J Gerstner; James E Krook; J Laurie; R Shreck
Randomized phase II studies in advanced colorectal carcinoma: a North Central Cancer Treatment Group study.
Cancer treatment reports 1983;67(11):1001-8.
1982: Harold E Windschitl; James E Krook; L K Everson; S A Cullinan; M Scott
Combination chemotherapy in patients with advanced colorectal carcinoma previously treated with 5-FU.
Cancer treatment reports 1982;66(12):2093-4.